文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

ICU获得性高钠血症与院内死亡率的相关性:基于MIMIC-III和eICU数据库

Association Between ICU-Acquired Hypernatremia and In-Hospital Mortality: Data From the Medical Information Mart for Intensive Care III and the Electronic ICU Collaborative Research Database.
PubMed 文献 · Crit Care Explor · 2020-12-16
一句话结论ICU获得性高钠血症与院内死亡率升高独立相关,血钠纠正速度>0.5 mmol/L/hr也可能有害。

该观察性研究利用MIMIC-III(n=46,476)和eICU(n=200,859)两个ICU队列,纳入ICU期间至少两次血钠在135-145 mmol/L且无连续两次低钠血症的成人患者,分别有23,445例和88,160例纳入分析。ICU获得性高钠血症发生率分别为9%和7%,与院内死亡率升高相关(MIMIC-III:OR 1.15,95%CI 1.13-1.17;eICU:OR 1.11,95%CI 1.10-1.12)。血钠纠正速度>0.5 mmol/L/hr与院内死亡率升高相关(MIMIC-III:OR 1.08,95%CI 1.03-1.13;eICU:OR 1.10,95%CI 1.06-1.13)。结论提示应预防ICU获得性高钠血症,一旦发生应避免过快纠正。

要点

  • ICU获得性高钠血症发生率约7%-9%,与院内死亡率升高独立相关(MIMIC-III OR 1.15,95%CI 1.13-1.17;eICU OR 1.11,95%CI 1.10-1.12)。
  • 血钠纠正速度>0.5 mmol/L/hr与院内死亡率升高相关(MIMIC-III OR 1.08,95%CI 1.03-1.13;eICU OR 1.10,95%CI 1.06-1.13)。
  • 研究纳入标准为ICU期间至少两次血钠135-145 mmol/L且无连续两次<135 mmol/L的成人患者。
  • 高钠血症组死亡率显著高于非高钠血症组(MIMIC-III:42% vs 20%;eICU:22% vs 6%,p<0.01)。
  • 临床应预防ICU获得性高钠血症,发生高钠血症时避免血钠纠正速度超过0.5 mmol/L/hr。

适用人群与场景

  • 成人ICU患者,ICU期间至少两次血钠在135-145 mmol/L且无连续两次血钠<135 mmol/L者纳入分析。
  • 排除标准原文未提及。

诊断标准与关键阈值

  • ICU获得性高钠血症定义原文未明确给出具体血钠阈值。
  • 血钠正常范围定义为135-145 mmol/L。
  • 低钠血症定义为血钠<135 mmol/L。
  • 快速纠正速率定义为>0.5 mmol/L/hr。

处置流程与药物剂量

  • 预防ICU获得性高钠血症的发生。
  • 若患者发生高钠血症,应避免血钠纠正速度>0.5 mmol/L/hr。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • ICU获得性高钠血症与院内死亡率升高相关,需警惕并预防。
  • 血钠纠正速度>0.5 mmol/L/hr可能有害,需避免过快纠正。

研究设计与关键结果

  • 研究类型:观察性研究,两个独立ICU队列(MIMIC-III和eICU)。
  • MIMIC-III队列:46,476例ICU患者中23,445例符合纳入标准,9%(n=2,172)发生高钠血症;高钠血症组院内死亡率42% vs 非高钠血症组20%(p<0.01);高钠血症与院内死亡率相关(OR 1.15,95%CI 1.13-1.17)。
  • eICU队列:200,859例ICU患者中88,160例符合纳入标准,7%(n=5,790)发生高钠血症;高钠血症组院内死亡率22% vs 非高钠血症组6%(p<0.01);高钠血症与院内死亡率相关(OR 1.11,95%CI 1.10-1.12)。
  • 快速纠正速率(>0.5 mmol/L/hr)与院内死亡率相关:MIMIC-III OR 1.08(95%CI 1.03-1.13),eICU OR 1.10(95%CI 1.06-1.13)。
  • eICU队列中快速纠正速率与院内死亡率差异有统计学意义,MIMIC-III队列中无统计学显著关联。
  • 原文未提及关键次要终点和不良事件的具体数据。

证据类型、等级与局限

  • 证据类型:观察性研究(两个ICU队列数据库分析)。
  • 证据等级或推荐强度原文未提及。
  • 局限:观察性设计,无法确定因果关系;MIMIC-III为单中心数据;快速纠正速率与死亡率的关联在MIMIC-III队列中无统计学显著性;原文未提及其他局限。

对床旁实践的改变

  • 应重视预防ICU获得性高钠血症,将其作为ICU管理质量指标之一。
  • 对已发生高钠血症的ICU患者,血钠纠正速度应避免超过0.5 mmol/L/hr。
  • 适用人群为成人ICU患者;原文未提及不适用人群。
  • 研究为观察性设计,结论需前瞻性验证,不能据此确定因果或制定强制性阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Describe the relationship between ICU-acquired hypernatremia and in-hospital mortality and investigate the optimal hypernatremia correction rate.

DESIGN SETTING PARTICIPANTS AND MEASUREMENTS: Observational study including two individual ICU cohorts. We used the Medical Information Mart for Intensive Care III v. 1.4 database consists of all ICU patients admitted to the Beth Israel Deaconess Medical Center in Boston from 2001 to 2012 (n = 46,476). The electronic ICU v. 2.0 database consists of all ICU patients admitted to 208 distinct hospitals across the United States from 2014 to 2015 (n = 200,859). We included all adult patients admitted to an ICU with two consecutive sodium samples within normal range (135-145 mmol/L) and without two consecutive hyponatremic samples (< 135 mmol/L) during the ICU stay.

RESULTS: Of 23,445 patients identified in Medical Information Mart for Intensive Care III, 9% (n = 2,172) developed hypernatremia during their ICU stay. In electronic ICU, 88,160 patients were identified and 7% (n = 5,790) developed hypernatremia. In both cohorts, patients with hypernatremia had a higher mortality (Medical Information Mart for Intensive Care III: 20% vs 42%; p < 0.01 and electronic ICU: 6% vs 22%; p < 0.01), with hypernatremia increasing the risk of in-hospital mortality (Medical Information Mart for Intensive Care III: odds ratio, 1.15; 95% CI, 1.13-1.17 and electronic ICU: odds ratio, 1.11; 95% CI, 1.10-1.12) and over time using a Cox regression. Rapid sodium correction rate (> 0.5 mmol/L/hr) was associated with an increased in-hospital mortality in both cohorts (Medical Information Mart for Intensive Care III: odds ratio, 1.08; 95% CI, 1.03-1.13 and electronic ICU: odds ratio, 1.10; 95% CI, 1.06-1.13). In the electronic ICU cohort, rapid correction rates were associated with a significant difference in in-hospital mortality, but there was no statistically significant association in the Medical Information Mart for Intensive Care III cohort.

CONCLUSIONS: ICU-acquired hypernatremia is associated with increased in-hospital mortality. Furthermore, a rapid sodium correction rates may be harmful. This suggests it is important to both prevent ICU-acquired hypernatremia and to avoid rapid correction rates if a patient becomes hypernatremic.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Olsen MH, Møller M, Romano S, et al. Association Between ICU-Acquired Hypernatremia and In-Hospital Mortality: Data From the Medical Information Mart for Intensive Care III and the Electronic ICU Collaborative Research Database. Crit Care Explor. 2020. PMID: 33354677. doi:10.1097/CCE.0000000000000304

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。